Influenza infections during winter always result in pressure within the NHS and this has been the case for many years, and is likely to...
Did you know that Woodley BioReg’s home county of Yorkshire is home to some of the most cutting-edge developments in medical devices, not only...
Dr Ash Ramzan, our principal consultant, recently took part in a Biosimilar Experts Roundtable Discussion hosted by biosimilar expert Dr Fiona Greer and joined...
Drug-device combination products are increasingly prevalent in modern medicine, and include a range of products such as medical devices that have been impregnated or...
As with many things post-Brexit, conformity marking of medical devices and IVDs has become much more complex for those looking to enter the market...
Woodley BioReg delivered successful scientific advice to accelerate biosimilars development and the registration of a biological product. Our client was based in the EU...
This is the fourth and final blog in our series on medicinal cannabis. To view the others, click here. Legal framework In the UK, there...
This is the third blog in our medicinal cannabis series. You can view the first and second article here to receive a deeper background and understanding...
Second in our medicinal cannabis blog series, this article explores the regulatory background of medicinal cannabis in the EU and the UK. If you...